Page last updated: 2024-08-21

delta-valerolactone and Breast Cancer

delta-valerolactone has been researched along with Breast Cancer in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jagadeeshan, S; Kumar, GS; Nair K, L; Nair S, A1

Other Studies

1 other study(ies) available for delta-valerolactone and Breast Cancer

ArticleYear
Folic acid conjugated δ-valerolactone-poly(ethylene glycol) based triblock copolymer as a promising carrier for targeted doxorubicin delivery.
    PloS one, 2013, Volume: 8, Issue:8

    Topics: Annexin A5; Apoptosis; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Doxorubicin; Drug Carriers; Drug Screening Assays, Antitumor; Esters; Female; Folic Acid; Humans; Inhibitory Concentration 50; Magnetic Resonance Spectroscopy; Micelles; Polyethylene Glycols; Pyrones; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Tetrazolium Salts; Thiazoles

2013